365 related articles for article (PubMed ID: 8276366)
1. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
[TBL] [Abstract][Full Text] [Related]
2. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
[TBL] [Abstract][Full Text] [Related]
3. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
[TBL] [Abstract][Full Text] [Related]
4. Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study.
Van der Rijt CC; Schalm SW; Meulstee J; Stijnen T
Gastroenterol Clin Biol; 1995; 19(6-7):572-80. PubMed ID: 7590022
[TBL] [Abstract][Full Text] [Related]
5. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
6. Treatment of benzodiazepine overdose with flumazenil. The Flumazenil in Benzodiazepine Intoxication Multicenter Study Group.
Clin Ther; 1992; 14(6):978-95. PubMed ID: 1286503
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of the native flumazenil for acute poisoning with benzodiazepines].
Zhu XH; Li JX; Wang F
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):576-8. PubMed ID: 12516410
[TBL] [Abstract][Full Text] [Related]
9. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
[TBL] [Abstract][Full Text] [Related]
10. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
Strauss E; Tramote R; Silva EP; Caly WR; Honain NZ; Maffei RA; de Sá MF
Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668
[TBL] [Abstract][Full Text] [Related]
11. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z
East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
Meier R; Gyr K
Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
[TBL] [Abstract][Full Text] [Related]
13. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
Laccetti M; Manes G; Uomo G; Lioniello M; Rabitti PG; Balzano A
Dig Liver Dis; 2000 May; 32(4):335-8. PubMed ID: 11515632
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
[TBL] [Abstract][Full Text] [Related]
15. Flumazenil: US clinical pharmacology studies.
Dunton AW; Schwam E; Pitman V; McGrath J; Hendler J; Siegel J
Eur J Anaesthesiol Suppl; 1988; 2():81-95. PubMed ID: 2842144
[TBL] [Abstract][Full Text] [Related]
16. Flumazenil: a benzodiazepine antagonist.
Hoffman EJ; Warren EW
Clin Pharm; 1993 Sep; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
[TBL] [Abstract][Full Text] [Related]
17. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.
Amodio P; Marchetti P; Del Piccolo F; Beghi A; Comacchio F; Carraro P; Campo G; Baruzzo L; Marchiori C; Gatta A
Clin Physiol; 1997 Sep; 17(5):533-9. PubMed ID: 9347201
[TBL] [Abstract][Full Text] [Related]
18. Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients.
Weinbroum A; Rudick V; Sorkine P; Nevo Y; Halpern P; Geller E; Niv D
Crit Care Med; 1996 Feb; 24(2):199-206. PubMed ID: 8605789
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma.
Ahboucha S; Pomier-Layrargues G; Mamer O; Butterworth RF
Neurochem Int; 2006 Sep; 49(4):372-8. PubMed ID: 16563564
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of pharmacological modulation of the GABAA-benzodiazepine receptor on hepatic encephalopathy in the rat: comparison with uremic encephalopathy.
Steindl P; Püspök A; Druml W; Ferenci P
Hepatology; 1991 Dec; 14(6):963-8. PubMed ID: 1660024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
